• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation?

作者信息

Byrareddy Siddappa N, Mohan Mahesh

机构信息

Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198, United States.

Texas Biomedical Research Institute, Southwest National Primate Research Center, San Antonio, TX 78227, United States.

出版信息

Brain Behav Immun. 2020 Jul;87:120-121. doi: 10.1016/j.bbi.2020.04.079. Epub 2020 Apr 28.

DOI:10.1016/j.bbi.2020.04.079
PMID:32360437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7187842/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb3e/7187842/42487148ee50/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb3e/7187842/42487148ee50/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb3e/7187842/42487148ee50/gr1_lrg.jpg

相似文献

1
SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation?严重急性呼吸综合征冠状病毒2型引起的呼吸窘迫：大麻素能否添加到抗病毒治疗中以减轻肺部炎症？
Brain Behav Immun. 2020 Jul;87:120-121. doi: 10.1016/j.bbi.2020.04.079. Epub 2020 Apr 28.
2
Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.β2-肾上腺素能通路能否成为抗击 SARS-CoV-2 炎症风暴综合征的新靶点？——癌症带来的启示。
Front Immunol. 2020 Sep 30;11:588724. doi: 10.3389/fimmu.2020.588724. eCollection 2020.
3
Cannabinoids Receptors in COVID-19: Perpetrators and Victims.大麻素受体在 COVID-19 中的作用：既是元凶也是受害者。
Curr Med Chem. 2023;30(34):3832-3845. doi: 10.2174/0929867329666220829145029.
4
The Immunopathology of COVID-19 and the Cannabis Paradigm.新型冠状病毒肺炎的免疫病理学与大麻范例。
Front Immunol. 2021 Feb 12;12:631233. doi: 10.3389/fimmu.2021.631233. eCollection 2021.
5
Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.Δ9-四氢大麻酚通过诱导免疫细胞凋亡，从而抑制细胞因子风暴，防止急性呼吸窘迫综合征导致的死亡。
Int J Mol Sci. 2020 Aug 28;21(17):6244. doi: 10.3390/ijms21176244.
6
Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature.新型冠状病毒2型感染后严重急性肌病：一例病例报告及近期文献综述
Skelet Muscle. 2021 Apr 21;11(1):10. doi: 10.1186/s13395-021-00266-5.
7
Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.COVID-19 患者的激肽释放酶-激肽系统阻断治疗以预防急性呼吸窘迫综合征。
Elife. 2020 Apr 27;9:e57555. doi: 10.7554/eLife.57555.
8
Countermeasure and therapeutic: A(1-7) to treat acute respiratory distress syndrome due to COVID-19 infection.对策与治疗：A(1 - 7)用于治疗由COVID - 19感染引起的急性呼吸窘迫综合征。
J Renin Angiotensin Aldosterone Syst. 2020 Oct-Dec;21(4):1470320320972018. doi: 10.1177/1470320320972018.
9
The Immune Response and Effectiveness of COVID-19 Therapies.新型冠状病毒肺炎免疫反应和治疗效果。
Adv Exp Med Biol. 2021;1321:115-126. doi: 10.1007/978-3-030-59261-5_10.
10
Effect of almitrine bismesylate and inhaled nitric oxide on oxygenation in COVID-19 acute respiratory distress syndrome.二甲磺酸阿米三嗪与吸入一氧化氮对新型冠状病毒肺炎急性呼吸窘迫综合征氧合的影响
Anaesth Crit Care Pain Med. 2020 Aug;39(4):471-472. doi: 10.1016/j.accpm.2020.05.014. Epub 2020 Jun 4.

引用本文的文献

1
Immunomodulatory effects of cannabinoids against viral infections: a review of its potential use in SARS-CoV2 infection.大麻素对病毒感染的免疫调节作用：对其在SARS-CoV2感染中潜在用途的综述
Virusdisease. 2024 Jun;35(2):342-356. doi: 10.1007/s13337-024-00871-0. Epub 2024 May 27.
2
Beta-Caryophyllene, a Cannabinoid Receptor Type 2 Selective Agonist, in Emotional and Cognitive Disorders.β-石竹烯，一种选择性大麻素受体 2 激动剂，在情绪和认知障碍中的作用。
Int J Mol Sci. 2024 Mar 11;25(6):3203. doi: 10.3390/ijms25063203.
3
Substances of abuse and their effect on SAR-CoV-2 pathogenesis.
滥用物质及其对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）发病机制的影响。
NeuroImmune Pharm Ther. 2023 Jul 31;2(3):301-316. doi: 10.1515/nipt-2023-0004. eCollection 2023 Sep.
4
Therapeutic Potential of Cannabis: A Comprehensive Review of Current and Future Applications.大麻的治疗潜力：对当前及未来应用的全面综述
Biomedicines. 2023 Sep 25;11(10):2630. doi: 10.3390/biomedicines11102630.
5
Detecting Tweets Containing Cannabidiol-Related COVID-19 Misinformation Using Transformer Language Models and Warning Letters From Food and Drug Administration: Content Analysis and Identification.使用Transformer语言模型和美国食品药品监督管理局的警告信检测包含与大麻二酚相关的COVID-19错误信息的推文：内容分析与识别
JMIR Infodemiology. 2023 Jan 23;3:e38390. doi: 10.2196/38390. eCollection 2023.
6
Phytocannabinoids Act Synergistically with Non-Steroidal Anti-Inflammatory Drugs Reducing Inflammation in 2D and 3D In Vitro Models.植物大麻素与非甾体抗炎药协同作用，在二维和三维体外模型中减轻炎症。
Pharmaceuticals (Basel). 2022 Dec 14;15(12):1559. doi: 10.3390/ph15121559.
7
Endocannabinoids, Anandamide and 2-Arachidonoylglycerol, as Prognostic Markers of Sepsis Outcome and Complications.内源性大麻素、花生四烯酸乙醇胺和 2-花生四烯酰甘油作为脓毒症结局和并发症的预后标志物。
Cannabis Cannabinoid Res. 2023 Oct;8(5):802-811. doi: 10.1089/can.2022.0046. Epub 2022 Jun 1.
8
The Medicinal Natural Products of Linn.: A Review.林奈的药用天然产物：综述。
Molecules. 2022 Mar 4;27(5):1689. doi: 10.3390/molecules27051689.
9
Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids and : A Comprehensive Review.大麻素的抗菌和抗病毒（SARS-CoV-2）潜力：综合评价。
Molecules. 2021 Nov 28;26(23):7216. doi: 10.3390/molecules26237216.
10
Cannabinoids for SARS-CoV-2 and is there evidence of their therapeutic efficacy?大麻素对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的作用及是否有其治疗效果的证据？
Turk J Biol. 2021 Aug 30;45(4):570-587. doi: 10.3906/biy-2105-73. eCollection 2021.